Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the neutrophil-DPP-1-protease axis in airway disease: current evidence and future indications.

Respiratory medicine·2026
Same author

Twelve-Month Real-World Outcomes of Tezepelumab in Severe Asthma: Clinical Remission, Biomarker Changes, and Trigger Burden-A SANI Multicenter Cohort.

Journal of personalized medicine·2026
Same author

Immunostimulant-induced maturation of monocyte-derived dendritic cells in respiratory infection prophylaxis.

Drugs in context·2026
Same author

Psychometric Validation of the Speed of Change in Feeling of Health (SCFH) Questionnaire: Findings from the NEWTON Sub-Study in Italian Asthma Patients.

Patient related outcome measures·2026
Same author

Optimizing Respiratory Care with NEXThaler: Bridging Technology and Treatment.

Medical devices (Auckland, N.Z.)·2026
Same author

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Allergy·2026
Same journal

Sustained clinical remission and relapse of severe eosinophilic asthma following long-term mepolizumab treatment.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same journal

Distinct peripheral coagulation-fibrinolysis profiles in eosinophilic and non-eosinophilic chronic rhinosinusitis.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same journal

Ultra-short recombinant Art v 1 immunotherapy induces rapid immune modulation in mugwort allergy: A Phase I trial.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same journal

Distinct allergen-specific T cell receptor clonotypes drive divergent immune programs in a cloned mouse model of atopic dermatitis.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same journal

Short-chain fatty acids modulate the development and the cell surface molecule expression of DCs by epigenetic regulation.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same journal

Skin symptoms during the pollen seasons and their association with the severity of seasonal allergic rhinitis in Yamanashi, Japan.

Allergology international : official journal of the Japanese Society of Allergology·2026
See all related articles

Related Experiment Video

Updated: Feb 22, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.7K

Sublingual Immunotherapy: Recent Advances.

Enrico Compalati1, Fulvio Braido1, Giorgio Walter Canonica1

  • 1Allergy and Respiratory Diseases Clinic, DIMI, University of Genoa, Genoa, Italy.

Allergology International : Official Journal of the Japanese Society of Allergology
|September 26, 2017
PubMed
Summary
This summary is machine-generated.

Sublingual immunotherapy (SLIT) for respiratory allergies is increasingly used globally due to proven efficacy and safety. Ongoing research explores its potential for other allergic conditions and improved formulations.

Keywords:
SLITallergydesensitizationrecent advancessublingual allergen immunotherapy

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.0K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.9K

Related Experiment Videos

Last Updated: Feb 22, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.7K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.0K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.9K

Area of Science:

  • Immunology
  • Allergology
  • Pharmacology

Background:

  • Sublingual immunotherapy (SLIT) for respiratory allergies is increasingly adopted worldwide.
  • Recent high-quality studies confirm its clinical efficacy and safety in various populations.
  • Preliminary evidence suggests benefits for asthma and potential applications in other allergic diseases.

Purpose of the Study:

  • To review the current status and future directions of sublingual immunotherapy for allergic conditions.
  • To highlight advancements in SLIT formulations and their mechanisms of action.
  • To identify challenges and future research needs for optimizing SLIT.

Main Methods:

  • Review of recent high-powered clinical trials and meta-analyses.
  • Examination of emerging research on perennial allergens and asthma.
  • Analysis of novel SLIT formulations and delivery systems.

Main Results:

  • SLIT demonstrates robust efficacy and safety for seasonal respiratory allergens in adults and children.
  • Emerging data supports SLIT for perennial allergens (e.g., house dust mites) and asthma.
  • Novel formulations aim to enhance SLIT safety and effectiveness, targeting immune responses.

Conclusions:

  • SLIT is a well-established and expanding treatment for respiratory allergies.
  • Further research is needed to identify optimal patient candidates and efficacy biomarkers.
  • Addressing compliance barriers is crucial for maximizing SLIT's clinical impact.